Ultrasound can improve cell viability, due to its ability to get molecules moving, and researchers have used it to increase blood flow to tissues in the process of healing and regenerating. Specifically, low-intensity ultrasound (LIUS) has been used to help regenerate cartilage and bone, and in tissue engineering to stimulate cells.
Surgeons use a patient's own fatty tissue (adipose tissue) in procedures including facial plastic surgery, treating burn victims, breast reconstruction, and surgery on the vocal cords. However, how well these tissue grafts survive can vary, and the time period after the surgery before a blood supply is reestablished is particularly crucial. If the graft does not get sufficient oxygen and glucose, and clear away waste, the grafted tissue will wither and die.
An international team of investigators, including researchers from Massachusetts Institute of Technology (MIT; Cambride, USA), the Center for Laryngeal Surgery and Voice Rehabilitation at Massachusetts General Hospital (Boston, MA, USA) and Ben Gurion University (Be'er Sheva, Israel), set out to evaluate whether ultrasound could improve the viability of grafted tissue during the postoperative period.
The researchers used adipose cells cultured from tissue left over from tummy-tuck operations as well as mouse muscle cells (C2C12 cells) for their experiments. Over a six-day period, the test cells were treated with LIUS at 30 mW/cm2 for short bursts of three or ten minutes. They assayed for the number of cells, metabolism (by observing how much glucose they consumed and how much lactate they produced), viability, and for signs of damage to the cells.
The C2C12 muscle cells stimulated with LIUS showed greater cell numbers and better viability than controls. Moreover, for the first time the researchers obtained preliminary evidence that LIUS can influence the viability of the cultured adipose cells (known as organoids) in an in vitro organ culture model. Adipose tissue treated with LIUS demonstrated considerably increased metabolic activity, and had fewer markers for tissue damage than tissue not treated with LIUS.
If the technique was used on a patient, the way that ultrasound might enhance molecular motion would probably depend on local variations in tissue density. "Depending on the location of the probe, one can expect variable effects of LIUS,” stated senior author Steven Zeitels, M.D., director of the Center for Laryngeal Surgery and Voice Rehabilitation.
It is also not clear whether the increased metabolic activity and proliferation of the cells seen in this experiment was simply due to LIUS's mechanical and thermal effect in stimulating molecules to move around more. "In the context of using LIUS to enhance autograft survival, the possibility that the LIUS can directly activate signaling pathways in implanted cells needs to be taken into account. It may eventually be possible to manipulate cellular responses by fine-tuning this technique,” said lead author Hyoungshin Park, Ph.D., from MIT.
According to the investigators, it is still not known whether these laboratory findings will be validated in in-vivo studies, but these early results suggest important avenues to pursue in efforts to improve graft survival.
The study was published online in May 2010 in the Journal of Tissue Engineering.
Related Links:
Massachusetts Institute of Technology
Center for Laryngeal Surgery and Voice Rehabilitation at Massachusetts General Hospital
Ben Gurion University
